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This study analyzed the prognostic significance of clinico‑pathologic factors, including the number 
of metastatic lymph nodes (LNs) and lymph node ratio (LNR), in patients with papillary thyroid 
carcinoma (PTC), and attempted to construct a disease recurrence prediction model using machine 
learning techniques. We retrospectively analyzed clinico‑pathologic data from 1040 patients 
diagnosed with PTC between 2003 and 2009. We analyzed clinico‑pathologic factors related to 
recurrence through logistic regression analysis. Among the factors that we included, only sex and 
tumor size were significantly correlated with disease recurrence. Parameters such as age, sex, tumor 
size, tumor multiplicity, ETE, ENE, pT, pN, ipsilateral central LN metastasis, contralateral central LNs 
metastasis, number of metastatic LNs, and LNR were input for construction of a machine learning 
prediction model. The performance of five machine learning models related to recurrence prediction 
was compared based on accuracy. The Decision Tree model showed the best accuracy at 95%, and 
the lightGBM and stacking model together showed 93% accuracy. Among those factors mentioned 
above, LNR and contralateral LN metastasis were used as important features in all machine learning 
prediction models. We confirmed that all machine learning prediction models showed an accuracy 
of 90% or more for predicting disease recurrence in PTC. LNR and contralateral LN metastasis were 
used as important features for constructing a robust machine learning prediction model. In the future, 
we have a plan to perform large‑scale multicenter clinical studies to improve the performance of our 
prediction models and verify their clinical effectiveness.
Over the past 20 years, the incidence of thyroid cancer has increased rapidly, and the most common histologic 
type of thyroid cancer is papillary thyroid carcinoma (PTC)1. PTC has an excellent prognosis and a better survival 
rate than other carcinomas;however, disease ultimately recurs in about 5–21% of PTC  patients2,3. In PTC patients 
with recurrent disease, surgical treatment is generally required, and re-operation poses additional medical costs 
and significant morbidity, compared to the initial surgery. Therefore, preventing recurrence in PTC patients can 
reduce and deteriorations in quality of life related to reoperation.
According to previous reports, tumor size, extrathyroidal extension (ETE), age, lymph node (LN) metasta-
sis, tumor multiplicity, and extranodal spread (ENE) are known risk factors for recurrence of  PTC4–6. In PTC, 
LN metastasis occurs in 20–90% of patients, and the number of metastatic LNs and lymph node ratio (LNR), 
representing metastatic LN burden, are known to be important prognostic factors associated with recurrence of 
 PTC7–13. Since various clinico-pathological factors and nodal factors (i.e., number of metastatic LNs and LNR) 
have been shown to be related to the recurrence of PTC, these factors should be considered in an integrated 
manner to establish a disease recurrence prediction model.
The 8th TNM staging system was revised by the American Joint Committee on Cancer (AJCC) to more accu-
rately predict the disease-specific survival of PTC patients. However, it does not reflect the biological behavior of 
PTC and has limitations in predicting the risk of  recurrence14–16. In particular, the number and size of metastatic 
LNs are not reflected in the revised TNM staging system. Also, the N classification of the revised TNM stage 
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system merely comprises three groups and does not consider other nodal  factors17–22. We presume that the more 
prognostic factors, such as number of metastatic LNs and LNR, that can be integrated into the TNM system, the 
more accurate the prediction model could be for predicting disease recurrence of PTC patients.
Machine learning technology is widely used in the medical field, especially in the fields of radiology, oph-
thalmology, and  dermatology23–28. However, studies on the construction of machine learning models that can 
be used to predict disease recurrence of PTC are extremely rare. Establishing a robust predictive model of PTC 
could help with selecting high-risk patients for intensified treatment tailored according to risk stratification 
and with suggesting candidates for active follow-up. This study analyzed the prognostic significance of vari-
ous clinico-pathologic nodal factors, including the number of metastatic LNs and LNR, in patients with PTC 
patients and attempted to construct a disease recurrence prediction model based on these factors using machine 
learning techniques.
Materials and methods
This study was approved by the Institutional Review Board (IRB) of Pusan University. Informed consent was 
not obtained from any participants because the IRB waived the need for individual informed consent. This 
retrospective research was performed in accordance with the Declaration of Helsinki. Medical data of patients 
diagnosed and treated for PTC at Pusan National University Hospital from June 2003 to December 2009 were 
analyzed retrospectively. We included patients who were diagnosed with PTC and underwent total thyroidectomy 
and central neck dissection with/without lateral neck dissection. We excluded (1) cases with a distant metastasis 
at the time of diagnosis, (2) patients who received previous surgery or radiotherapy to the head and neck area, 
and (3) cases with insufficient clinical data that were lost to follow-up after surgery. Finally, 1040 patients were 
included in the study, including 147 males and 893 females. Their ages ranged from 13 to 79 years and the mean 
age was 48.5 years. Tumor stage was classified according to the 8th AJCC staging system.
To detect disease recurrence, all patients underwent physical examination, ultrasound, and thyroglobulin 
measurement every 6–12 months after surgery. If necessary, additional imaging studies such as computed tomog-
raphy, whole body iodine scan, and positron emission tomography were performed. Recurrence was defined as 
a case in which a new lesion was detected that was not previously observed in the imaging studies and which 
was pathologically confirmed through fine needle aspiration cytology.
Tumor size, ETE, multiplicity, ENE, and TNM stage were analyzed. The surgical specimens from central 
neck dissection were divided into ipsilateral and contralateral areas according to the location of the tumor, and 
therein the number of metastatic LNs and the total number of harvested LNs were recorded. LNR was calculated 
by dividing the number of metastatic LNs by the total number of harvested LNs. The cut-off value of LNR was 
determined in consideration of optimized sensitivity and specificity for predicting disease recurrence using 
receiver operating characteristic curves (ROC). The optimal value of LNR was used to construct machine learn-
ing models for predicting disease recurrences.
Machine learning was performed based on the supervised learning method, and a variety of machine learning 
models was used including the decision tree, random forest, XGBoost, and LightGBM, and Stacking models. 
Learning was performed with the five models mentioned above, and accuracy was used to evaluate model perfor-
mance. Scikit-learn version 12.3 was used for model building and learning. 80% of the data set was classified as 
the training set and was used for learning, and the remaining 20% was used as a test set. To account for selection 
bias, the five-fold-cross-validation technique was applied.
Patient clinical information, pathologic information, recurrence, and cause of recurrence were analyzed. The 
Chi-square or independent two-sample t-test were used to evaluate differences in variables between two inde-
pendent groups. The multivariate Cox proportional hazards regression model was used to evaluate the effect of 
several variables on disease recurrence. p values < 0.05 were considered indicative of statistical significance. Statis-
tical analyses were performed using python 3.8 version and SPSS version 25.0 for Windows (SPSS, Chicago, IL).
Results
A total of 1040 patients were included in this study, and all patients underwent total thyroidectomy and central 
neck dissection. In total, 180 patients (17.3%) underwent lateral neck dissection simultaneously due to lateral 
LN metastasis. The average tumor size was 12.4 mm (range 2–125). ETE findings were observed in 586 (56.3%) 
patients, and tumor multiplicity was observed in 178 (17.1%) patients. ENE findings were observed in 159 
patients (15.3%). With respect to T classification, 508 patients were classified as T1, 46 patients were T2, 483 
patients were T3, and three patients were T4. The average number of metastatic LNs in the central compartment 
was 1.73 (range 0–19), and the average number of LNs removed was 8.32 (range 0–36). The average LNR value 
was 0.20 (range 0–1). The mean follow-up period was 79.0 months (range 46–149), and the total number of recur-
rence events during the study period was 41. Other clinico-pathological information is summarized in Table 1.
The cut-off value for the LNR was set to show the optimal sensitivity and specificity for recurrence prediction. 
Regarding the prediction of recurrence, LNR showed a statistically significant correlation (p value =  < 0.001), with 
an AUC value of 0.752, and an LNR value of 0.24 was set as the optimal cut-off value. There were 519 patients 
(49.9%) with an LNR-of 0; 179 (17.2%) with an LNR value greater than 0, but less than 0.24; and 342 (32.9%) 
with an LNR value of 0.24 or more. Recurrence-free survival was significantly lower in the patient group with 
LNR > 0.24, compared to the other two groups (Fig. 1A). A cut-off value for the number of metastatic LNs was 
devised to obtain optimal sensitivity and specificity for recurrence prediction. The number of metastatic LNs was 
statistically significantly correlated with recurrence (p value =  < 0.001), with an AUC value of 0.742. A value of 2 
was set as the cut-off for the number of metastatic LNs. There were 519 patients (49.9%) with 0 metastatic LNs, 
161 (15.5%) with one LN metastasis, and 360 (34.6 with two or more LN metastases. Recurrence-free survival 
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was analyzed by dividing patients into these three groups and was significantly decreased lower in patients with 
two or more metastatic LNs (Fig. 1B).
We analyzed the association between clinico-pathologic factors and recurrence through univariate analysis. 
Sex, tumor size, ETE, pT classification, pN classification, number of metastatic LNs, and LNR were significantly 
correlated with disease recurrence. Clinico-pathologic factors related to recurrence were also analyzed with 
logistic regression for multivariate analysis. Among the factors included in the analysis, only sex and tumor size 
showed significant correlations with disease recurrence (Table 2).
To build a machine learning prediction model, the algorithm was trained using parameters of age, sex, tumor 
size, tumor multiplicity, ETE, ENE, pT, pN, ipsilateral central LN metastasis, contralateral central LN metastasis, 
number of metastatic LNs, and LNR. Since disease recurred in only 41 of 1040 cases, the SMOTE technique 
was applied to adjust for the imbalance in learning data. The performance of five machine learning models for 
recurrence prediction was compared based on accuracy. The decision tree model showed the best accuracy at 
95%, and the LightGBM and stacking models showed accuracies of 93%. Table 3 summarizes the performance of 
the five models. The tree structure of the decision tree model was visualized using graphic software, and feature 
importance was also visualized and analyzed (Fig. 2). In other machine learning models, feature importance was 
explored to determine the major factors that influence the prediction of recurrence in PTC patients. Although 
the feature importance results differed slightly between machine learning models, LNR and contralateral LN 
metastasis were consistently important features in all models (Table 4).
Discussion
The revised 8th TNM staging system is suitable for assessing the risk of death in patients with PTC, but not for 
predicting the risk of recurrence. Age, aggressive histology, tumor size, and LNs metastasis are known risk factors 
associated with PTC  recurrence29. The 2015 American Thyroid Association guidelines suggested the number 
and size of metastatic LNs and ENE as risk factors for  recurrence30,31. Meanwhile, LNR, calculated by dividing 
the number of metastatic LNs by the total number of removed LNs, has been reported in previous studies as 
a risk factor for recurrence of  PTC13,32,33. Lee et al.34 reported that the performance of recurrence prediction 
increased when LNR was incorporated into the existing 2015 ATA risk stratification. In our study, the sensitivity 
and specificity for predicting disease recurrence were optimized when an LNR value of 0.24 was set as a cut-off. 
The number of metastatic LNs also showed a statistically significant correlation with the prediction of disease 
recurrence when 2 or more LNs was set as the cut-off value. To construct a robust prediction model for disease 
recurrence in PTC, these all factors mentioned above should be considered and integrated into the model.
In univariate analysis of risk factors for PTC recurrence, sex, tumor size, ETE, pT, pN, number of metastatic 
LNs, and LNR were significantly correlated with recurrence. In multivariate analysis using logistic regression, 
only tumor size showed a significant correlation with disease recurrence. Because logistic regression was used to 
analyze prognostic factors based on a linear combination between variables, if the degree of correlation between 
variables was high, the analysis was limited with overfitted results. On the other hand, since machine learning 
Table 1.  Clinical information for all patients (n = 1040) enrolled in the study.
Variable No. of patients (%)
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Figure 1.  (A) The cut-off value for the lymph node ratio (LNR) was determined in consideration of the 
sensitivity and specificity optimized to predict disease recurrence using a receiver operating characteristic curve 
(ROC). Recurrence-free survival of the patient group with LNR > 0.24 was significantly decreased. (B) The 
cut-off value for the number of metastatic LNs was determined in consideration of the sensitivity and specificity 
optimized to predict disease recurrence using a ROC. The recurrence-free survival of the patient group with two 
or more metastatic LNs was significantly decreased. (The graph was made by statistical software SPSS version 
25.0 for windows).
Table 2.  Logistic regression analysis for disease recurrence adjusted for clinico-pathologic factors. CI 
confidence interval, ETE extrathyroidal extension, LN lymph node, LNR lymph node ratio.
Factor Hazard ratio 95% CI p value
Sex 2.393 1.128–5.077 0.023
Size 1.030 1.007–1.052 0.010
ETE 3.105 0.697–13.834 0.137
pT 1.547 0.810–2.954 0.186
pN 0.790 0.170–3.683 0.765
Number of metastatic CLNs 1.619 0.582–4.502 0.356
LNR 1.337 0.480–3.725 0.578
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models do not assume a linear combination of variables used, the effect of correlation between variables can be 
diminished. Therefore, we can put all those prognostic factors including nodal factors such as LNR and number 
of metastatic LNs into the model and constructed machine learning prediction model. When analyzing the 
feature importance of parameters used for machine learning model construction, we noted that contralateral 
LN metastasis and LNR were used at high frequencies for machine learning model construction in all machine 
learning models, along with other clinical factors, including tumor size and age.
Among the machine learning techniques used in this study, the decision tree model showed the highest 
accuracy, followed by the Ensemble models, including LightGBM and stacking techniques. All of the machine 
learning models showed accuracies of 90% or more. However, since the models were trained based on data from 
1000 patients, more patient data would be required to increase the performance of our models and to apply them 
in clinical practice. Also, additional research is needed to address the following limitations: Since this was a 
retrospective study conducted at a single institution, the influence of selection bias cannot be excluded. In addi-
tion, considering the indolent features of PTC, a short follow-up period is less optimal for detecting recurrence 
in PTC patients. Nevertheless, this study is of value as the first study on machine learning models of predicting 
PTC disease recurrence based clinico-pathologic factors.
In this study, various machine learning models were constructed for predicting disease recurrence in PTC 
patients, and all of the models had a confirmed accuracy of 90% or more. In the future, large-scale clinical studies 
on many patients should be performed to improve the performance of our prediction models, and multicenter 
clinical studies will be needed to verify their clinical effectiveness.
Table 3.  Performance results for the machine learning models.
Model Accuracy Precision Recall F1 score
Decision tree 0.95 0.66 0.18 0.28
Random forest 0.91 0.25 0.27 0.26
XGBoost 0.92 0.25 0.18 0.21
LightGBM 0.93 0.28 0.18 0.22
Stacking 0.93 0.33 0.18 0.23
Figure 2.  The structure of the decision tree model was visualized using graphic software. (The graph was made 
using by python version 3.8, scikit-learn version 12.3, and graphviz software, All these software are open-sourec 
program).
Table 4.  Top five features of importance among machine learning models. LN lymph node, LNR lymph node 
ratio.
Rank Decision tree Random forest XGBoost LightGBM
1st Contralateral CLN metastasis LNR Tumor size Age
2nd LNR Ipsilateral CLNs metastasis Age Tumor size
3rd Age Contralateral CLNs metastasis Ipsilateral CLNs metastasis Ipsilateral CLNs metastasis
4th Tumor size LNR LNR
5th Age Contralateral CLNs metastasis Contralateral CLNs metastasis
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